Close
Nordic 9Nordic 9

Kemin Industries (investor - Corporate Investor)

France
See something wrong or missing? Let us know
Offices:Paris
Average round investment:26.8M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: France Afyren
Mostly invests in: France France (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Kemin Industries

Name Criteria
United Kingdom Arix Bioscience plc
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States KB Partners
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Roquette Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China Zhejiang NHU
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France BOLD - Business Opportunities for L'Oréal Development
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Didier Rousseau
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Inserm Transfert Initiative
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Ubiquity Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China Viva BioInnovator
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada adMare BioInnovations
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top